| Dr Lorie Ann Thomas-schultz, DO | |
|
15900 Medical Dr South, Findlay, OH 45840 | |
| (419) 425-8131 | |
| (567) 525-5326 |
| Full Name | Dr Lorie Ann Thomas-schultz |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 15900 Medical Dr South, Findlay, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568440097 | NPI | - | NPPES |
| 2074848 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 34006597 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blanchard Valley Hospital | Findlay, OH | Hospital |
| Bluffton Hospital | Bluffton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blanchard Valley Medical Practice Llc | 9234168147 | 68 |
News Archive
The Coalition for Pulmonary Fibrosis is praising Social Security Commissioner Michael Astrue's announcement this morning via press release that Idiopathic Pulmonary Fibrosis (IPF), also known as Pulmonary Fibrosis (PF), and a listing of 37 other diseases and life-threatening medical conditions are the latest additions to Social Security's "Compassionate Allowances" program.
Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.
American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.
Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.
An investigational tyrosine kinase inhibitor, ponatinib, has shown high levels of activity in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
› Verified 1 days ago
| Entity Name | Blanchard Valley Medical Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962501627 PECOS PAC ID: 9234168147 Enrollment ID: O20050811000177 |
News Archive
The Coalition for Pulmonary Fibrosis is praising Social Security Commissioner Michael Astrue's announcement this morning via press release that Idiopathic Pulmonary Fibrosis (IPF), also known as Pulmonary Fibrosis (PF), and a listing of 37 other diseases and life-threatening medical conditions are the latest additions to Social Security's "Compassionate Allowances" program.
Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.
American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.
Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.
An investigational tyrosine kinase inhibitor, ponatinib, has shown high levels of activity in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
› Verified 1 days ago
| Entity Name | Specialty Physicians Of Blanchard Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689835415 PECOS PAC ID: 2668547613 Enrollment ID: O20080826000542 |
News Archive
The Coalition for Pulmonary Fibrosis is praising Social Security Commissioner Michael Astrue's announcement this morning via press release that Idiopathic Pulmonary Fibrosis (IPF), also known as Pulmonary Fibrosis (PF), and a listing of 37 other diseases and life-threatening medical conditions are the latest additions to Social Security's "Compassionate Allowances" program.
Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.
American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.
Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.
An investigational tyrosine kinase inhibitor, ponatinib, has shown high levels of activity in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lorie Ann Thomas-schultz, DO 301 W Wallace St, Findlay, OH 45840 Ph: (419) 424-0180 | Dr Lorie Ann Thomas-schultz, DO 15900 Medical Dr South, Findlay, OH 45840 Ph: (419) 425-8131 |
News Archive
The Coalition for Pulmonary Fibrosis is praising Social Security Commissioner Michael Astrue's announcement this morning via press release that Idiopathic Pulmonary Fibrosis (IPF), also known as Pulmonary Fibrosis (PF), and a listing of 37 other diseases and life-threatening medical conditions are the latest additions to Social Security's "Compassionate Allowances" program.
Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.
American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.
Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.
An investigational tyrosine kinase inhibitor, ponatinib, has shown high levels of activity in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
› Verified 1 days ago
Dr. Joseph Aloysius Weingates Iii, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1818 Chapel Dr, Suite C, Findlay, OH 45840 Phone: 419-424-1055 Fax: 419-424-9448 | |
George Abate, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1818 Chapel Dr, Suite C, Findlay, OH 45840 Phone: 419-427-0809 | |
Carmen Doty-armstrong, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main Cross St, Findlay, OH 45840 Phone: 419-420-0904 Fax: 419-420-1893 | |
Dr. Mahendra C. Parekh, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 West Wallace Street, Suite B-4, Findlay, OH 45840 Phone: 419-422-6717 | |
Dr. Alan T. Tong, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1641 North Lake Ct, Findlay, OH 45840 Phone: 419-425-1510 Fax: 419-425-1736 | |
Dr. Marilyn Joy Kindig Stahl, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 301 W Wallace St, Findlay, OH 45840 Phone: 419-424-0180 | |
Dr. Emil Christian Ziegler, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 532 Yorkshire Dr, Findlay, OH 45840 Phone: 419-423-8822 |